Anti-X3CL1/ CX3CL1/ ABCD-3 monoclonal antibody

Anti-X3CL1/ CX3CL1/ ABCD-3 antibody for FACS & in-vivo assay

Target products collectionGo to CX3CL1/CX3CL1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T34405-Ab-1/ GM-Tg-hg-T34405-Ab-2Anti-Human CX3CL1 monoclonal antibodyHuman
GM-Tg-rg-T34405-Ab-1/ GM-Tg-rg-T34405-Ab-2Anti-Rat CX3CL1 monoclonal antibodyRat
GM-Tg-mg-T34405-Ab-1/ GM-Tg-mg-T34405-Ab-2Anti-Mouse CX3CL1 monoclonal antibodyMouse
GM-Tg-cynog-T34405-Ab-1/ GM-Tg-cynog-T34405-Ab-2Anti-Cynomolgus/ Rhesus macaque CX3CL1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T34405-Ab-1/ GM-Tg-felg-T34405-Ab-2Anti-Feline CX3CL1 monoclonal antibodyFeline
GM-Tg-cang-T34405-Ab-1/ GM-Tg-cang-T34405-Ab-2Anti-Canine CX3CL1 monoclonal antibodyCanine
GM-Tg-bovg-T34405-Ab-1/ GM-Tg-bovg-T34405-Ab-2Anti-Bovine CX3CL1 monoclonal antibodyBovine
GM-Tg-equg-T34405-Ab-1/ GM-Tg-equg-T34405-Ab-2Anti-Equine CX3CL1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T34405-Ab-1/ GM-Tg-hg-T34405-Ab-2; GM-Tg-rg-T34405-Ab-1/ GM-Tg-rg-T34405-Ab-2;
GM-Tg-mg-T34405-Ab-1/ GM-Tg-mg-T34405-Ab-2; GM-Tg-cynog-T34405-Ab-1/ GM-Tg-cynog-T34405-Ab-2;
GM-Tg-felg-T34405-Ab-1/ GM-Tg-felg-T34405-Ab-2; GM-Tg-cang-T34405-Ab-1/ GM-Tg-cang-T34405-Ab-2;
GM-Tg-bovg-T34405-Ab-1/ GM-Tg-bovg-T34405-Ab-2; GM-Tg-equg-T34405-Ab-1/ GM-Tg-equg-T34405-Ab-2
Products NameAnti-CX3CL1 monoclonal antibody
Formatmab
Target NameCX3CL1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CX3CL1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    BiosimilarGMP-Bios-ab-461Pre-Made Quetmolimab biosimilar, Whole mAb, Anti-CX3CL1 Antibody: Anti-ABCD-3/C3Xkine/CXC3/CXC3C/NTN/NTT/SCYD1/fractalkine/neurotactin therapeutic antibody
    Target AntigenProducts DevelopingMulti-species X3CL1/ CX3CL1/ ABCD-3 VLP (virus-like particle) (Products Developing)
    CytokineGM-Tg-g-T34405-Ag-1chemokine (C-X3-C motif) ligand 1 (CX3CL1) protein
    ORF Viral VectorvGMLV000860human CX3CL1 Lentivirus particle
    ORF Viral VectorvGMLP001884human CX3CL1 Lentivirus particle
    ORF Viral VectorpGMLP001884human CX3CL1 Lentivirus plasmid
    ORF Viral VectorpGMLV000860human CX3CL1 Lentivirus plasmid
    ORF Viral VectorpGMLPm002323mouse Cx3cl1 Lentivirus plasmid
    ORF Viral VectorvGMLPm002323mouse Cx3cl1 Lentivirus particle


    Target information

    Target IDGM-T34405
    Target NameCX3CL1
    Gene ID6376,20312,89808,574225,487265,101084670,517354,102150350
    Gene Symbol and SynonymsABCD-3,C3Xkine,CX3C,CX3CL1,CXC3,CXC3C,D8Bwg0439e,FK,fractalkine,neurotactin,NTN,NTT,SCYD1
    Uniprot AccessionP78423,O55145
    Uniprot Entry NameX3CL1_HUMAN,X3CL1_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target, INN Index, Cytokine Target
    DiseaseCancer
    Gene EnsemblENSG00000006210
    Target ClassificationTumor-associated antigen (TAA)

    The target: CX3CL1, gene name: CX3CL1, also named as ABCD-3, C3Xkine, CXC3, CXC3C, NTN, NTT, SCYD1, fractalkine, neurotactin. This gene belongs to the CX3C subgroup of chemokines, characterized by the number of amino acids located between the conserved cysteine residues. This is the only member of the CX3C subgroup, which contains three amino acids between cysteine residues, resulting in a Cys-X-X-X-Cys configuration. The encoded protein contains an extended mucin-like stalk with a chemokine domain on top, and exists in both a membrane-anchored form where it acts as a binding molecule, or, in soluble form, as a chemotactic cytokine. The mature form of this protein can be cleaved at the cell surface, yielding different soluble forms that can interact with the G-protein coupled receptor, C-X3-C motif chemokine receptor 1 gene product. This gene plays a role in a wide range of diseases, including cancer, vasculitis, neuropathies, atherosclerosis, inflammatory diseases, and in human immunodeficiency virus infections. [provided by RefSeq, Sep 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.